Medical Oncology

Doç. Dr. Murat Ayhan

Doctor and researcher Liv Hospital Vadistanbul İstanbul
Carcinoma, Non-Small-Cell LungLung NeoplasmsBreast NeoplasmsCarcinoma, HepatocellularLiver NeoplasmsPeritoneal NeoplasmsMelanomaStomach NeoplasmsNeoplasmsColorectal Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Carcinoma, Non-Small-Cell Lung 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 4 publications
  • Breast Neoplasms 3 publications
  • Carcinoma, Hepatocellular 2 publications
  • Liver Neoplasms 2 publications
  • Peritoneal Neoplasms 2 publications
  • Melanoma 2 publications
  • Stomach Neoplasms 2 publications
  • Neoplasms 2 publications
  • Colorectal Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

  • Meme kanseri
  • Akciğer Kanseri
  • Kolorektal kanserler
  • Jinekolojik ve ürogenital kanserler
  • Moleküler Onkoloji

CV

Education and experience

From source

Experience

  • ExperienceLiv Hospital Uluslivhospital.com
  • ExperienceAdıyaman Üniversitesi Eğitim ve Araştırma Hastanesilivhospital.com
  • Experienceİstanbul Ümraniye Eğitim ve Araştırma Hastanesilivhospital.com

Education

  • 2001Kızıltepe Anadolu Lisesilivhospital.com
  • 2007Dicle Üniversitesi Tıp Fakültesilivhospital.com
  • 2014İstanbul Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesilivhospital.com
  • 2021Kartal Şehir Hastanesilivhospital.com
  • 2023Tıbbi Onkoloji Doçentilivhospital.com

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Vadistanbullivhospital.comFrom source
  • Area of workCarcinoma, Non-Small-Cell LungExtracted from 4 publications · Model version —From source
  • Publications52 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:55https://www.livhospital.com/doc-dr-murat-ayhanlivhospital.com

Scientific work

Publications on Carcinoma, Non-Small-Cell Lung

52 publications

  1. Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma

    Journal of International Medical Research, 2026

    DOI 10.1177/03000605251386599 PMID 41521150 Open-access full textSource: OpenAlex

  2. Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source: OpenAlex

  3. Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study

    Molecular and Clinical Oncology, 2025

    DOI 10.3892/mco.2025.2846 PMID 40297501 Open-access full textSource: OpenAlex

  4. Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  5. Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG)

    Cancers, 2025

    DOI 10.3390/cancers17243895 PMID 41463146 Open-access full textSource: OpenAlex

  6. Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer

    Future Oncology, 2024

    DOI 10.2217/fon-2023-0763 PMID 38328890 Source: OpenAlex

  7. The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma

    Journal of Immunotherapy, 2024

    DOI 10.1097/cji.0000000000000508 PMID 38333962 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 citations (Europe PMC) Source: OpenAlex

  9. HALP Score as a New Prognostic Factor for Patients with Metastatic Bladder Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.12.1405 PMID 38062597 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens

    Oncology Letters, 2023

    DOI 10.3892/ol.2023.13795 PMID 37123028 2 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 52 publications